CA2100314A1 - Pharmaceutical Composition for the Treatment of Chronic Skin Ulcers - Google Patents
Pharmaceutical Composition for the Treatment of Chronic Skin UlcersInfo
- Publication number
- CA2100314A1 CA2100314A1 CA 2100314 CA2100314A CA2100314A1 CA 2100314 A1 CA2100314 A1 CA 2100314A1 CA 2100314 CA2100314 CA 2100314 CA 2100314 A CA2100314 A CA 2100314A CA 2100314 A1 CA2100314 A1 CA 2100314A1
- Authority
- CA
- Canada
- Prior art keywords
- treatment
- pharmaceutical composition
- skin ulcers
- chronic skin
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A pharmaceutical composition for the treatment of chronic skin ulcers comprises as active ingredient a mixture of 4-chloro-3,5-dimethylphenol and boric acid, together with a pharmaceutically acceptable carrier therefor. The composition of the invention is effective for clearing bacterial infection and stimulating cell growth.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2100314 CA2100314C (en) | 1993-07-12 | 1993-07-12 | Pharmaceutical composition for the treatment of chronic skin ulcers |
FR9408541A FR2707497A1 (en) | 1993-07-12 | 1994-07-11 | Pharmaceutical composition for the treatment of chronic skin ulcers. |
GB9413939A GB2280370A (en) | 1993-07-12 | 1994-07-11 | Pharmaceutical composition for the treatment of chronic skin ulcers |
DE19944424548 DE4424548A1 (en) | 1993-07-12 | 1994-07-12 | Pharmaceutical composition for the treatment of chronic skin ulcers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2100314 CA2100314C (en) | 1993-07-12 | 1993-07-12 | Pharmaceutical composition for the treatment of chronic skin ulcers |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2100314A1 true CA2100314A1 (en) | 1995-01-13 |
CA2100314C CA2100314C (en) | 1996-04-16 |
Family
ID=4151918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2100314 Expired - Fee Related CA2100314C (en) | 1993-07-12 | 1993-07-12 | Pharmaceutical composition for the treatment of chronic skin ulcers |
Country Status (4)
Country | Link |
---|---|
CA (1) | CA2100314C (en) |
DE (1) | DE4424548A1 (en) |
FR (1) | FR2707497A1 (en) |
GB (1) | GB2280370A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100222301A1 (en) * | 2010-02-06 | 2010-09-02 | Javid Mihan Jafari | Topical drug for treatment and/or prevention of diabetic neuropathy, microangiopathy and diabetic and non diabetic ulcers and wound infection |
-
1993
- 1993-07-12 CA CA 2100314 patent/CA2100314C/en not_active Expired - Fee Related
-
1994
- 1994-07-11 GB GB9413939A patent/GB2280370A/en not_active Withdrawn
- 1994-07-11 FR FR9408541A patent/FR2707497A1/en not_active Withdrawn
- 1994-07-12 DE DE19944424548 patent/DE4424548A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
FR2707497A1 (en) | 1995-01-20 |
CA2100314C (en) | 1996-04-16 |
DE4424548A1 (en) | 1995-01-19 |
GB9413939D0 (en) | 1994-08-31 |
GB2280370A (en) | 1995-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2274074A1 (en) | Novel compounds with analgesic effect | |
CA2239174A1 (en) | Novel compounds with analgesic effect | |
CA2180816A1 (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
CA2193337A1 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
ITMI922953A1 (en) | DOUBLE BIOLOGICAL ACTIVITY OF NO SYNTHASIS AND CYCLOOXYGENES PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM. | |
CA2068324A1 (en) | Metal-peptide compositions and methods for stimulating hair growth | |
MY132705A (en) | Novel compounds with analgesic effect | |
EP1466606A3 (en) | Use of inosine for the manufacture of a medicament for stimulating axonal outgrowth of central nervous system neurons | |
AU5201493A (en) | Method and pharmaceutical preparations for reducing the activity of cells | |
AU4697393A (en) | Pharmaceutical and/or cosmetic preparation and the use of the preparation | |
CA2094137A1 (en) | Novel hydroxamic acid and n-hydroxyurea derivatives and their use | |
CA2186269A1 (en) | Wound healing | |
DE69631609D1 (en) | Tricyclische erythromycinderivate | |
AU7001487A (en) | Difluorohalomethoxyphenyl derivative and miticide comprising said derivative as active ingredient | |
CA2139385A1 (en) | Products containing g-csf and tnf binding protein | |
CA2200480A1 (en) | New use of prostaglandins | |
WO1994008613A3 (en) | Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy | |
CA2031817A1 (en) | Use of thrombospondin to promote wound healing | |
AU7588094A (en) | Dihalopropene compound, insecticide/acaricide containing said diahalopropene compound as active ingredient, and intermediate compound for use in production of said dihalopropene compound | |
DE69723864D1 (en) | Ethyliden-derivate tricyclyscher carbapenems | |
EP0393707A3 (en) | Bioactive compounds associated with liposomes and their use in pharmaceutical preparations | |
AU591892B2 (en) | Peptides | |
CA2120319A1 (en) | Pharmaceutical for the treatment of skin disorders | |
ITMI922742A0 (en) | COMPOUNDS WITH THERAPEUTIC ACTIVITY USEFUL FOR THE TREATMENT OF DISEASES RELATED TO GLUTATHIONE DEFICIENCY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
CA2100314A1 (en) | Pharmaceutical Composition for the Treatment of Chronic Skin Ulcers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |